Biohit Oyj (HEL:BIOBV)
Finland flag Finland · Delayed Price · Currency is EUR
2.610
-0.050 (-1.88%)
Apr 29, 2026, 10:54 AM EET

Biohit Oyj Company Description

Biohit Oyj, a biotechnology company, manufactures and sells bind acetaldehyde, diagnostic products, and systems for diagnostic analysis for the use of research institutions, healthcare, and industry worldwide.

The company offers GastroPanel quick test NT, a rapid and quantitative immunochromatographic test for the detection of Helicobacter pylori and atrophic gastritis; GastroPanel test, a blood test for diagnosis of the function and structure of stomach mucosa; GastroSoft, a software application designed to assist clinicians and general practitioners in interpreting GastroPanel test results; and GP Reader NT for the quantitative determination of various analytes in human samples.

It also provides BIOHIT active B12 (HoloTC) test, BIOHIT total 25OH vitamin D test, and BIOHIT Calprotectin; BIOHIT ColonView quick test for detection of fecal occult blood (FOB) in stool samples; BIOHIT Celiac quick test, a qualitative in vitro immunochromatographic test aiding in diagnosis of celiac disease; BIOHIT H.

pylori UFT300 and H.pylori tests for the diagnosis of H,pylori infection; lactose intolerance quick test kit; and Gluten Immunogenic Peptides test.

In addition, it offers Acetium acetaldehyde binding products, such as the Acetium lozenge to help quit smoking and Acetium capsule for the protection of the stomach.

Further, the company provides monoclonal antibodies for use in the areas of cellular pathology, neurobiology, oncology, and human gastric biomarkers research.

Additionally, it offers BIOHIT FAEX sample system for the collection and handling of stool samples. The company was incorporated in 1988 and is headquartered in Helsinki, Finland.

Biohit Oyj
Biohit Oyj logo
Country Finland
Founded 1988
Industry Medical Devices
Sector Healthcare
Employees 46
CEO Jussi Hahtela

Contact Details

Address:
Laippatie 1
Helsinki, 00880
Finland
Phone 358 9 773 861
Website biohithealthcare.com

Stock Details

Ticker Symbol BIOBV
Exchange Nasdaq Helsinki
Fiscal Year January - December
Reporting Currency EUR
ISIN Number FI0009005482
SIC Code 3821

Key Executives

Name Position
Jussi Hahtela President and Chief Executive Officer
Prof. Osmo Antero Suovaniemi M.D., Ph.D. Founder, Deputy Chief Executive Officer, Member of Scientific Advisory Board and Director
Jussi Sorvo Chief Financial Officer
Kati Piironen Chief Technology Officer
Ville Suovaniemi Head of Global Sales and Marketing
Yulia Kubacheva Head of Diagnostics Department - Biohit Russia
Graham Johnson B.Sc. Managing Director of Biohit Healthcare Ltd - UK